<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
New fill/finish partnership with BioConnection provides end-to-end drug product development under 1 contract!   Read the press release

Global CDMO Tours & Expert Insights

Get a glimpse into our development, analytical and clinical and commercial manufacturing services across our seven sites. 

Click here to find our on-demand webinars


Discover the innovations and processes behind our manufacturing success

Precision in Practice: Optimizing Large-Scale Mammalian Commercial Manufacturing

Hear from our expert Mark Davis, Director of Manufacturing Science and Technology, as he discusses how to optimize large-scale mammalian and mAb manufacturing for commercial supply.

Creating CGT Controls for Seamless Scale-Up from Development to Manufacturing

Learn from AGC Biologics' Process Development Manager, Meghan Nelson, as she speaks on how we ensure successful process development across all scales and prevent issues before they happen.

Check out our video series from our experts in Milan about the future of cell & gene therapy

Addressing Cell Therapy Trends

Listen to Alessandra Gatti, Cell Process Development Director at AGC Biologics talk about emerging trends within the cell therapy industry.

Delivering a GMP Process for ATMPs

Francesca Bellintani, MSAT Director, and overall expert on manufacturing cell and gene therapies shares how her team creates proven cGMP processes.

Building Better Analytical Methods for ATMPs

AGC Biologics' Analytical Method Development Director, Francesca Rossetti, talks about how we are evolving analytical testing capabilities for advanced therapies.

Navigating the Changing ATMP Market

Luca Alberici, Sr. VP and General Manager, of the AGC Biologics site in Milan discusses the changing cell and gene therapy market.

Creating New Standards for ATMP Manufacturing

Dive into how AGC Biologics is shaping the future of manufacturing for advanced therapies with Sabrina Cazzaniga, Sr. Director of GMP Manufacturing.

Building Standardized Viral Vector Platforms

Margherita Neri, Director of Vector Process Development, shares how AGC Biologics has built multiple successful viral vector platforms.

Addressing Regulatory & Quality in Cell and Gene

Listen to Giuliana Vallanti on how AGC Biologics has made quality a priority for all our processes, leading to successful regulatory approval for many advanced therapy products. 


We offer industry-leading process development with more than 95% of our analytics performed in-house.

Virtually tour our sites & facilities across the globe

Global Facilities Tour

AGC Biologics can develop, manufacture and deliver what you need, wherever you are in the world — right when you need it.

Seattle Campus Tour

Explore AGC Biologics global headquarters site, providing mammalian and microbial services in Seattle, Washington, USA. 

Copenhagen Campus Tour

Tour AGC Biologics largest site and our EU biologics hub in Copenhagen, Denmark that specializes in mammalian and microbial services.

Chiba Facility Tour

The AGC Biologics facility in Chiba is the only CDMO site in Japan with a global resource network and offers mammalian, microbial, and plasmid DNA development and manufacturing.

Heidelberg Facility Tour

Explore our European hub for microbial, plasmid DNA, and messenger RNA with over 40 years of experience in Heidelberg, Germany.

Heidelberg 2023 Expansion Completion

Virtually tour the expansion of AGC Biologics' Heidelberg site, which includes a new warehouse, sampling & weighing center, additional lab spaces and expanded microbial, pDNA, and mRNA capabilities.

Milan Facility Tour

The Milan, Italy facility is AGC Biologics' Cell & Gene Center of Excellence and was the first advanced therapy site approved in Europe for GMP manufacturing of clinical and commercial supplies.

Milan 2023 Expansion Completion

The expansion of the Milan facility allows for large-scale commercial viral vector work, suspension capabilities (PD, GMP), both allogeneic and autologous cell therapy​, and small-scale fill/finish.

Longmont Campus Tour

This facility is the North American Cell & Gene Therapy CDMO hub for AGC Biologics, offering end-to-end viral vector and cell therapy services in Longmont, Colorado, US.

Boulder Facility Tour

Peak into AGC Biologics large-scale commercial manufacturing site for mammalian cell projects in Boulder, Colorado, USA.